Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial

Breast cancer hormone receptor negativity, triple-negative type, mastectomy and not receiving adjuvant radiotherapy were associated with axillary recurrence after sentinel lymph node biopsy

(2019) Chikako Sekine et al.   Asian Journal of Surgery

Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center

(2019) Carlos A. Garcia-Etienne et al.   EJSO

Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer

(2018) Monica Morrow et al.   JAMA Oncology

Restricted Axillary Staging in Clinically and Sonographically Node-Negative Early Invasive Breast Cancer (c/iT1–2) in the Context of Breast Conserving Therapy: First Results Following Commencement of the Intergroup-Sentinel-Mamma (INSEMA) Trial

(2017) T. Reimer et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2017) Armando E. Giuliano et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centers

(2016) Adam Gondos et al.   ACTA ONCOLOGICA

Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial

(2016) Giuseppe Canavese et al.   ANNALS OF SURGICAL ONCOLOGY

A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer

(2016) Miriam W. Tsao et al.   ANNALS OF SURGICAL ONCOLOGY

SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodes

(2016) Corrado Tinterri et al.   BREAST

POSNOC: A Randomised Trial Looking at Axillary Treatment in Women with One or Two Sentinel Nodes with Macrometastases

(2015) A. Goyal et al.   CLINICAL ONCOLOGY

Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage Breast Cancer

(2015) Katharine Yao et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Recommendation for Omitting Axillary Lymph Node Dissection Should Be Individualized in Patients With Breast Cancer With One or Two Positive Sentinel Lymph Nodes

(2014) Ioannis A. Voutsadakis et al.   JOURNAL OF CLINICAL ONCOLOGY

Axillary Treatment in Women With One or Two Sentinel Nodes With Macrometastases: More Evidence Is Needed to Inform Practice

(2014) Amit Goyal et al.   JOURNAL OF CLINICAL ONCOLOGY

Axillary Dissection Can Be Avoided in the Majority of Clinically Node-Negative Patients Undergoing Breast-Conserving Therapy

(2013) Lynn T. Dengel et al.   ANNALS OF SURGICAL ONCOLOGY

Reporting of Noninferiority and Equivalence Randomized Trials

(2013) Gilda Piaggio et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The post ACOSOG Z0011 era: Does our new understanding of breast cancer really change clinical practice?

(2012) U. Güth et al.   EJSO

Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence

(2012) Archie Bleyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing Trial

(2011) Abigail S. Caudle et al.   ANNALS OF SURGICAL ONCOLOGY

Sentinel Lymph Node Biopsy in Breast Cancer

(2010) Umberto Veronesi et al.   ANNALS OF SURGERY

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

(2010) David N Krag et al.   LANCET ONCOLOGY

Comparison of Sentinel Lymph Node Biopsy Alone and Completion Axillary Lymph Node Dissection for Node-Positive Breast Cancer

(2009) Karl Y. Bilimoria et al.   JOURNAL OF CLINICAL ONCOLOGY

Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? One-Year Outcomes of Sentinel Node Biopsy Versus Axillary Clearance (SNAC): A Randomized Controlled Surgical Trial

(2008) Grantley Gill et al.   ANNALS OF SURGICAL ONCOLOGY